Global Option. From the Effective Date up to the second (2nd) anniversary of the Effective Date (the “Global Option Period”), Cue hereby grants LGC an exclusive option to receive an exclusive (even as to Cue and its Affiliates) worldwide license (the “Global License”), with the right to grant sublicenses through multiple tiers, under the Cue Global Product Technology to elect one additional Antigen (that is not a Cue Global Reserved Antigen) and to use, Research, Develop, Manufacture and Commercialize Global Compounds and Global Products in the Field (such option, the “Global Option”).
Appears in 2 contracts
Sources: Collaboration, License and Option Agreement (Cue Biopharma, Inc.), Collaboration, License and Option Agreement (Cue Biopharma, Inc.)